Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 8Gastrointestinal 3Sarcoma 1NET 1Head & Neck 1Gynecologic 1Endocrine 1Dermatologic 1

Conditions

Ovarian Neoplasms 142Endometrial Neoplasms 85Uterine Cervical Neoplasms 71Breast Neoplasms 42Fallopian Tube Neoplasms 38Colorectal Neoplasms 34Carcinoma, Non-Small-Cell Lung 32Pancreatic Neoplasms 24Neoplasms 23Prostatic Neoplasms 22Neoplasm Metastasis 21Stomach Neoplasms 19Triple Negative Breast Neoplasms 18Urinary Bladder Neoplasms 17Esophageal Neoplasms 17Melanoma 16Squamous Cell Carcinoma of Head and Neck 15Lung Neoplasms 15Carcinoma, Renal Cell 15Carcinoma, Ovarian Epithelial 15Head and Neck Neoplasms 14Sarcoma 13Carcinoma, Hepatocellular 13Uterine Neoplasms 11Colonic Neoplasms 11Cholangiocarcinoma 11Carcinoma, Transitional Cell 11Rectal Neoplasms 10Vulvar Neoplasms 9Small Cell Lung Carcinoma 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thoracic Neoplasms × Gynecologic × 30 days × Clear all
NCT05462717 2026-05-15

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

Revolution Medicines, Inc.

Phase 1 Active not recruiting
222 enrolled
GastrointestinalGynecologicThoracic

Appendiceal Neoplasms, Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Stomach Neoplasms, Thoracic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡